Skip to main content
Clinical Trials/NCT06724666
NCT06724666
Recruiting
N/A

Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression

Babes-Bolyai University2 sites in 1 country198 target enrollmentApril 1, 2025

Overview

Phase
N/A
Intervention
Not specified
Conditions
Anxiety Disorders
Sponsor
Babes-Bolyai University
Enrollment
198
Locations
2
Primary Endpoint
Internalizing problems
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this clinical trial is to test the efficacy of a transdiagnostic Internet-delivered interventions for Romanian adolescents with anxiety and/ or depression. The main questions it aims to answer are:

  • What is the clinical efficacy of the Internet-delivered intervention?
  • How accurate is the prediction model in predicting who will respond to treatment? Participants will undergo non-invasive fMRI to measure variability in brain signal as a proxy of the neural systems' adaptability before receiving the intervention, then they will be allocated either to the Internet-delivered intervention or control group.

Detailed Description

To the best of investigators' knowledge, this is the first clinical trial conducted with adolescents diagnosed with anxiety/and or depressive disorders that tests the accuracy of a prediction model based on fMRI to investigate participants' response to a transdiagnostic Internet-delivered intervention.

Registry
clinicaltrials.gov
Start Date
April 1, 2025
End Date
June 30, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Babes-Bolyai University
Responsible Party
Principal Investigator
Principal Investigator

Costina-Ruxandra Poetar

Assistant professor

Babes-Bolyai University

Eligibility Criteria

Inclusion Criteria

  • elevated symptoms of anxiety or depression/ internalizing problems (T score\> 60) at intake (based on Youth self-report completed by adolescents)
  • primary diagnosis of an anxiety/depressive disorder based on DSM-5 criteria according to ADIS-5-C/P interview
  • age 13-17
  • able to read and understand Romanian language
  • Currently unmedicated or on stable and adequate doses of medication for at least 6 weeks before treatment onset
  • Internet access

Exclusion Criteria

  • severe mental disorder (psychosis, severe depression, bipolar disorder, based on clinical interview)
  • any condition that interferes with the protocol implementation (e.g., physical illness or sensory impairment that interferes with behavioral tasks such as exposure, behavioral activation, unavailable for the next 3 months),
  • active suicidal ideation (assessed by child psychiatrist during clinical interview) in the last month
  • currently following CBT/ psychotherapy for anxiety/depression, in the last 6 months
  • fMRI incompatible (based on safety questionnaire)
  • Being diagnosed with an intellectual disability, pervasive developmental disorder, an alcohol and/or substance dependence disorder, reading disabilities (based on clinical interview).
  • Current treatment with benzodiazepines

Outcomes

Primary Outcomes

Internalizing problems

Time Frame: baseline, after 8 weeks of intervention, 6 months follow-up

Change from baseline in internalizing problems. Revised Children's Anxiety and Depression Scale (RCADS) completed by adolescents.

Secondary Outcomes

  • Clinical diagnosis(administered pre-baseline, post-baseline (after 8 week waitlist period), after 8 weeks of intervention)
  • Global functioning(baseline, after 8 weeks of intervention, 6 months follow-up)
  • Severity(baseline, after 8 weeks of intervention, 6 months follow-up)
  • Improvement(after 8 weeks of intervention, 6 months follow-up)
  • Comorbid problems(baseline, after 8 weeks of intervention, 6 month follow-up)
  • Life satisfaction(baseline, after 8 weeks of intervention, 6 months follow-up)
  • Satisfaction with the Internet-delivered intervention(after 8 weeks of intervention)
  • Working alliance(after 8 weeks of intervention)
  • Automatic thoughts(baseline, after 8 weeks of intervention, 6 month follow-up)
  • Credibility and expectations(week 2)
  • Credibility and expectations based on primary outcome measure(baseline)
  • Anxiety and depressive symptoms(baseline, at each 2 weeks during treatment duration, after 8 weeks of intervention, 6 months follow-up)
  • Avoidance(baseline, after 8 weeks of intervention, 6 month follow-up)
  • Parental distress(baseline)
  • Adolescent anxiety and depressive symptoms as reported by parents(baseline, after 8 weeks of intervention, 6 month follow-up)
  • Parental accommodations(baseline)

Study Sites (2)

Loading locations...

Similar Trials